MC2091A1 - Procedes pour la preparation de composes a action anti-inflammatoire et de formulations pharmaceutiques les contenant - Google Patents
Procedes pour la preparation de composes a action anti-inflammatoire et de formulations pharmaceutiques les contenantInfo
- Publication number
- MC2091A1 MC2091A1 MC902102A MC2102A MC2091A1 MC 2091 A1 MC2091 A1 MC 2091A1 MC 902102 A MC902102 A MC 902102A MC 2102 A MC2102 A MC 2102A MC 2091 A1 MC2091 A1 MC 2091A1
- Authority
- MC
- Monaco
- Prior art keywords
- compounds
- processes
- preparation
- pharmaceutical formulations
- formulations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898902472A GB8902472D0 (en) | 1989-02-03 | 1989-02-03 | Anti-inflammatory aryl derivatives |
| GB898919314A GB8919314D0 (en) | 1989-08-25 | 1989-08-25 | Anti-inflammatory aryl derivatives |
| GB898924867A GB8924867D0 (en) | 1989-11-03 | 1989-11-03 | Anti-inflammatory aryl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC2091A1 true MC2091A1 (fr) | 1991-02-15 |
Family
ID=27264299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC902102A MC2091A1 (fr) | 1989-02-03 | 1990-02-02 | Procedes pour la preparation de composes a action anti-inflammatoire et de formulations pharmaceutiques les contenant |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0384594B1 (no) |
| JP (1) | JPH02270855A (no) |
| KR (1) | KR900012892A (no) |
| AT (1) | ATE96427T1 (no) |
| AU (1) | AU624896B2 (no) |
| CA (1) | CA2009201A1 (no) |
| DE (1) | DE69004119T2 (no) |
| DK (1) | DK0384594T3 (no) |
| ES (1) | ES2060015T3 (no) |
| FI (1) | FI900536A0 (no) |
| HU (1) | HU208523B (no) |
| IL (1) | IL93259A0 (no) |
| MC (1) | MC2091A1 (no) |
| NO (1) | NO171906C (no) |
| NZ (1) | NZ232350A (no) |
| PT (1) | PT93049A (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120752A (en) * | 1989-12-28 | 1992-06-09 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
| US5476873A (en) * | 1990-07-25 | 1995-12-19 | Abbott Laboratories | Acetylene derivatives having lipoxygenase inhibitory activity |
| JPH06256285A (ja) * | 1990-12-11 | 1994-09-13 | Pfizer Pharmaceut Co Ltd | ヒドロキサム酸誘導体およびその用途 |
| US5130485A (en) * | 1991-04-23 | 1992-07-14 | Eli Lilly And Company | N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents |
| US5283361A (en) * | 1991-04-23 | 1994-02-01 | Eli Lilly And Company | N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors |
| US5140047A (en) * | 1991-05-03 | 1992-08-18 | Smithkline Beecham Corporation | Lipoxygenase inhibitors |
| DE4204686A1 (de) * | 1992-02-17 | 1993-08-19 | Gruenenthal Gmbh | Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln |
| US5326787A (en) * | 1992-05-12 | 1994-07-05 | Abbott Laboratories | Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity |
| GB9308652D0 (en) * | 1993-04-27 | 1993-06-09 | Wellcome Found | Anti-inflammatory compounds |
| TW418089B (en) * | 1993-08-19 | 2001-01-11 | Pfizer | Pharmaceutical composition comprising phenoxyphenyl cyclopentenyl hydroxyureas (the dextrorotary isomers) |
| US5468760A (en) * | 1993-11-08 | 1995-11-21 | American Home Products Corporation | Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein |
| US5428048A (en) * | 1993-11-08 | 1995-06-27 | American Home Products Corporation | Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents |
| US5459154A (en) * | 1993-11-08 | 1995-10-17 | American Home Products Corporation | N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein |
| EP0891772A3 (en) * | 1997-06-18 | 1999-05-19 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflamatory drug and phenylpropionic acid derivative |
| CN100427609C (zh) | 2001-10-24 | 2008-10-22 | 加利福尼亚大学董事会 | 鉴定5-脂氧化酶作为引起动脉硬化症的主要基因 |
| WO2013007371A2 (en) * | 2011-07-13 | 2013-01-17 | Eth Zurich | Kinetic resolution of chiral amines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO165341C (no) * | 1985-03-16 | 1991-01-30 | Wellcome Found | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrearylderivater. |
| US4728670A (en) * | 1986-06-04 | 1988-03-01 | E. R. Squibb & Sons, Inc. | Biphenyl hydroxamic acids |
| US4897422A (en) * | 1987-02-10 | 1990-01-30 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
| ES2053609T3 (es) * | 1987-04-24 | 1994-08-01 | Abbott Lab | Derivados de urea inhibidores de lipoxigenasa. |
| PL154186B1 (en) * | 1987-07-15 | 1991-07-31 | Wellcome Found | Method for manufacturing arylic derivatives of the hydroxamic acid |
-
1990
- 1990-02-02 DK DK90301090.8T patent/DK0384594T3/da active
- 1990-02-02 DE DE90301090T patent/DE69004119T2/de not_active Expired - Fee Related
- 1990-02-02 EP EP90301090A patent/EP0384594B1/en not_active Expired - Lifetime
- 1990-02-02 AT AT90301090T patent/ATE96427T1/de not_active IP Right Cessation
- 1990-02-02 MC MC902102A patent/MC2091A1/xx unknown
- 1990-02-02 NO NO900504A patent/NO171906C/no unknown
- 1990-02-02 FI FI900536A patent/FI900536A0/fi not_active IP Right Cessation
- 1990-02-02 PT PT93049A patent/PT93049A/pt unknown
- 1990-02-02 NZ NZ232350A patent/NZ232350A/en unknown
- 1990-02-02 KR KR1019900001225A patent/KR900012892A/ko not_active Application Discontinuation
- 1990-02-02 HU HU90656A patent/HU208523B/hu not_active IP Right Cessation
- 1990-02-02 CA CA002009201A patent/CA2009201A1/en not_active Abandoned
- 1990-02-02 IL IL93259A patent/IL93259A0/xx unknown
- 1990-02-02 ES ES90301090T patent/ES2060015T3/es not_active Expired - Lifetime
- 1990-02-02 JP JP2024286A patent/JPH02270855A/ja active Pending
- 1990-02-02 AU AU49088/90A patent/AU624896B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NZ232350A (en) | 1992-04-28 |
| IL93259A0 (en) | 1990-11-29 |
| DE69004119D1 (de) | 1993-12-02 |
| HUT53071A (en) | 1990-09-28 |
| NO900504D0 (no) | 1990-02-02 |
| NO171906B (no) | 1993-02-08 |
| DE69004119T2 (de) | 1994-03-24 |
| KR900012892A (ko) | 1990-09-03 |
| PT93049A (pt) | 1990-08-31 |
| AU4908890A (en) | 1990-08-09 |
| AU624896B2 (en) | 1992-06-25 |
| NO171906C (no) | 1993-05-19 |
| HU208523B (en) | 1993-11-29 |
| HU900656D0 (en) | 1990-04-28 |
| ES2060015T3 (es) | 1994-11-16 |
| FI900536A0 (fi) | 1990-02-02 |
| EP0384594A1 (en) | 1990-08-29 |
| CA2009201A1 (en) | 1990-08-03 |
| EP0384594B1 (en) | 1993-10-27 |
| NO900504L (no) | 1990-08-06 |
| DK0384594T3 (da) | 1993-12-06 |
| JPH02270855A (ja) | 1990-11-05 |
| ATE96427T1 (de) | 1993-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MC2091A1 (fr) | Procedes pour la preparation de composes a action anti-inflammatoire et de formulations pharmaceutiques les contenant | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| CA2029599A1 (en) | Medicaments containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses | |
| IE894048L (en) | New therapeutically active compound and a process for its¹preparation | |
| SE8804692L (sv) | Nya 17b-oh-19-nor-steroider substituerade i 17 -staellning, foerfarande foer framstaellning daerav, anvaendning daerav som laekemedel och farmaceutiska kompositioner innehaallande dem | |
| FR2698788B1 (fr) | Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation. | |
| IT1226727B (it) | Farmaci precursori della dopamina. | |
| NZ225408A (en) | Acetohydroxamic acid derivatives and compositions thereof | |
| IL92358A0 (en) | Diaryl compounds,their preparation and pharmaceutical compositions containing them | |
| KR880007074A (ko) | 의약품 | |
| ATE84035T1 (de) | Antivirale tetrahydroimidazo(1,4)benzodiazepin-2- one. | |
| ATE40127T1 (de) | 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel. | |
| HU9500175D0 (en) | Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives | |
| DK644487D0 (da) | Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse | |
| JO1679B1 (en) | A new, therapeutically active compound and method for preparing it | |
| TH8696A (th) | สารประกอบแอริลซึ่งต้านการอักเสบ | |
| ES8300709A1 (es) | Un metodo para la preparacion de derivados de pirazolidinona | |
| JO1660B1 (en) | Benzimidazole compounds are a therapeutically effective substitute for chlorine and processes for preparing and using them | |
| TH6256A (th) | อนุพันธ์ แอริล สารต่อต้านการอักเสบ | |
| TH8696EX (th) | สารประกอบแอริลซึ่งต้านการอักเสบ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |